Deal facts
- Buyer
- Novacyt Holdings UK Limited
- Target
- Southern Cross Diagnostics Pty Ltd
- Deal value
- Not disclosed
- Announced
- 2 March 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- Australia
- Consideration
- Not stated
Sources
Novacyt Holdings UK Limited has agreed to acquire Southern Cross Diagnostics Pty Ltd in a strategic acquisition within the molecular diagnostics sector. The transaction was announced and completed on 2 March 2026, with the target operating out of Australia. The deal value and specific consideration terms were not disclosed to the public at the time of the announcement.
This acquisition brings the Australian diagnostic business under the ownership of the UK-based parent company, expanding its presence in the Southern Hemisphere. The integration of Southern Cross Diagnostics into the Novacyt group marks a significant step for the buyer in the molecular diagnostics field. The transaction is now complete following the successful closing on the announced date.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Novacyt Holdings UK Limited to acquire Southern Cross Diagnostics Pty Ltd
{ "headline": "Completion of Acquisition", "issuer": "Novacyt S.A. (CDI) (NCYT)", "announcement_date": "2026-03-02T07:00:00", "category_code": "Completion of Acquisition", "body": "Disclaimer* \n\n \n\n \n\n Novacyt S.A. \n\n (\"Novacyt\", the \"Company\" or the \"Group\") \n\n \n\n Completion of Acquisition \n\n \n\n Paris, France, and Manchester, UK - 2 March 2026 - Novacyt S.A.
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
GSK plc to acquire Nuvalent, Inc
GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Volex plc to acquire Kepler SignalTek Ltd
Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…
- Buyer
- Volex plc
- Target
- Kepler SignalTek Ltd
- Deal value
- USD 89,400,000
- Deal type
- strategic acquisition
Lixte Biotechnology Holdings, Inc. to acquire Nomad Transportable Power Systems, Inc.
Lixte Biotechnology Holdings, Inc. has agreed to acquire Nomad Transportable Power Systems, Inc. in a strategic acquisition within the Healthcare sector. The transaction…
- Buyer
- Lixte Biotechnology Holdings, Inc.
- Target
- Nomad Transportable Power Systems, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Public Company Management Corporation to acquire Physicians Capital Management Corporation
Public Company Management Corporation has agreed to acquire Physicians Capital Management Corporation in a strategic acquisition within the healthcare sector. The transa…
- Buyer
- Public Company Management Corporation
- Target
- Physicians Capital Management Corporation
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Novacyt Holdings UK Limited
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive